Regeneron, Sanofi arthritis drug fails late-stage study in COVID-19 patients – Reuters

Regeneron, Sanofi arthritis drug fails late-stage study in COVID-19 patients – Reuters

Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a late-stage study testing it in COVID-19 patients.

Read More…

You May Also Like